Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Auxilium Pharmaceuticals, Inc.    

AUXILIUM PHARMACEUTICALS, INC.
Mes dernières consult.
Most popular
  Report  
SummaryNewsCompany 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Auxilium Pharmaceuticals, Inc. : and FCB I LLC File Lawsuit Against Watson for Infringement of Testim® Patents

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/24/2012 | 01:58pm CEST

MALVERN, Pa., and WILMINGTON, Del., May 24, 2012/PRNewswire/ -- Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) ("Auxilium") and FCB I LLC ("FCB") announced today that they filed a lawsuit against Watson Laboratories, Inc. (NV); Watson Pharmaceuticals, Inc.; and Watson Pharma, Inc. (collectively, "Watson") for infringement of FCB's ten patents listed in the U.S. Food and Drug Administration's ("FDA's") Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the "Orange Book") as covering Testim® 1% testosterone gel.  The lawsuit was filed in the United States District Court for the District of New Jerseyon May 23, 2012.

Auxilium and FCB filed this lawsuit in response to a notice letter sent by Watson Laboratories, Inc. (NV) regarding its filing with the FDA of Abbreviated New Drug Application ("ANDA") No. 09

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on AUXILIUM PHARMACEUTICALS,
2015EXCLUSIVE : Drugmaker Endo vying for Salix takeover
RE
2015AUXILIUM PHARMACEUTICALS : Announces Results from Special Meeting of Stockholder..
PR
2015Endo International to Join S&P 500 as Boston Beer Moves Up to MidCap List
DJ
2014AUXILIUM PHARMACEUTICALS : Sobi's Xiapex receives positive opinion by CHMP for t..
PR
2014AUXILIUM PHARMACEUTICALS : Announces Date for Special Meeting of Stockholders
PR
2014AUXILIUM PHARMACEUTICALS : Presents XIAFLEX For Peyronie's Disease Data At SMSNA..
PR
2014AUXILIUM PHARMACEUTICALS : Presents STENDRA Data At SMSNA Scientific Meeting
PR
2014AUXILIUM PHARMACEUTICALS : Endo Announces Early Termination of HSR Act Waiting P..
PR
2014AUXILIUM PHARMACEUTICALS : Endo Announces Early Termination of HSR Act Waiting P..
PR
2014AUXILIUM PHARMACEUTICALS : to Present XIAFLEX and STENDRA Data at SMSNA Scientif..
PR
More news
News from SeekingAlpha
2015Vivus' Stendra To Get A Re-Launch 
2015FDA imposes limits on testosterone drugs and labeling changes to warn of pote.. 
2015WINNERS CIRCLE 2014 TOP HEDGE FUND M : Healthcare Funds, Nine Of Top Ten Spots 
Chart AUXILIUM PHARMACEUTICALS,
Duration : Period :
Auxilium Pharmaceuticals,  Technical Analysis Chart | US05334D1072 | 4-Traders
Managers
NameTitle
Suketu P. Upadhyay Chief Financial Officer, Director & Executive VP
Rajiv De Silva Director
Guy T. Donatiello Director
Karen A. Wallace Treasurer & Senior Vice President
Caroline B. Manogue Secretary, Chief Legal Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
AUXILIUM PHARMACEUTICALS, INC.0
CSL LIMITED14.47%55 642
BIOGEN-15.42%54 858
ALEXION PHARMACEUTICALS-9.83%23 977
GRIFOLS-5.92%17 583
BIOMARIN PHARMACEUTICAL-7.95%14 452